INVENIA Co. Ltd (079950) fair value: what the stock is really worth
As of Nov 6, 2026: fair value (intrinsic value) of INVENIA Co. Ltd stock KRW 1,805, price KRW 1,245, upside +45.0%, quality 40 out of 100. Rating: undervalued. Calculated from audited financials with 6 of our 26 valuation models and 37 quality factors, updated daily.
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 4, 2026.
How to read this chart
60‑month range 812.00 KRW – 9,375 KRW · fair‑value band 1,623 KRW – 1,981 KRW · the 1,245 KRW price screens below the 1,805 KRW fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 4, 2026.
Follow INVENIA Co. in your weekly email
Every Wednesday you see whether INVENIA Co. is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
It offers dry etchers, vacuum alignment systems, pattern AOI systems, and macro inspection systems for LCD production; and plasma treatment, vacuum transfer, vacuum lamination, mask particle inspection and repair, evaporation particle AOI, and film encapsulation monitoring inspection systems, as well as aligners and pressers, and hot wind circulation pressers for the OLED production.
The company was formerly known as LIG Invenia Co., Ltd. and changed its name to INVENIA Co., Ltd. in March 2016. The company was founded in 2001 and is based in Seongnam, South Korea.
Stock analysis
INVENIA Co. Ltd (079950) currently trades at 1,245 KRW, while our model-based Fair Value estimate is 1,805 KRW, implying the stock looks roughly 31% undervalued today.
Show more
Valuation
Bull case: the Growth DCF group reads highest at a median of 1,064 KRW per share, and 2 of the 6 models we run sit above the 1,245 KRW price.
Bear case: the Asset-Based group reads lowest at 451.20 KRW, and 4 of the 6 models stay below the price. Data coverage for this calculation is low.
Scenario range: 1,623 KRW (bear) to 1,981 KRW (bull), the price of 1,245 KRW sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 40/100 (below-average quality), in the Technology sector.
Weak Growth: Revenue is shrinking: the last year, the last three and the last five years are all negative.
INVENIA Co. Ltd reported revenue of 18.4B KRW in FY2025 versus 134B KRW in FY2021, a compound −39.2%/yr. Reported net income was −12.7B KRW in FY2025.
Key figures
Market cap 18.0B KRW (≈ $13.3M) Micro · P/S ratio 0.18 · Net margin −4.9% · Return on equity −4,901% · Return on assets (EBIT) −10.6% (5-year average) · Operating margin −0.5% · Revenue growth (YoY) −75.2% · EPS growth (YoY) −60.7%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 9 out of 100 (low confidence).
What moves the price
The share trades about 78% below its 52-week high and 53% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Technology peers we cover trades at 4% fair-value upside, at 45%, 079950 screens cheaper than that median.
Fair Value models
Bear1,623 KRWFair Value 1,805 KRWBull1,981 KRW
Price 1,245 KRW · Upside +45.0%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
FCF DCF1,040 KRW1,321 KRW1,805 KRW81
Growth DCF1,071 KRW1,339 KRW1,766 KRW80
5Y Revenue Exit659.89 KRW767.41 KRW921.56 KRW74
All 6 models by family
DCF Models
FCF DCF1,040 KRW1,321 KRW1,805 KRW81
5Y Revenue Exit659.89 KRW767.41 KRW921.56 KRW74
10Y Revenue Exit811.42 KRW902.64 KRW990.41 KRW68
Asset-Based
NCAV (Graham)336.71 KRW451.20 KRW673.43 KRW54
Growth DCF
Growth DCF1,071 KRW1,339 KRW1,766 KRW80
Rev-Margin DCF659.89 KRW789.04 KRW958.68 KRW74
The fair value above starts from this blend and is adjusted for a cyclical trough year.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.18/100
Revenue is shrinking: the last year, the last three and the last five years are all negative.
Revenue growth 1 year
−15.7%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−31.3%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−33.4%
Start year 2020 (pandemic). Over 10 years: −14.6% a year
Revenue growth 13 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−1.7%
’14
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
3.0% (2020) → −46.7% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
not computed
Growth Forecast
A lot of optimism in the price
The price assumes more growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+37.0%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect
n/a
No analyst forecast available.
After inflation (South Korea: IMF forecast 2.1% a year to 2030, 2.1% from 2016 to 2025) that is about +34.2% a year for the price.
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Semiconductors & Semiconductor Equipment · 48 stocks
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Is INVENIA Co. Ltd (079950) overvalued or undervalued?
As of Nov 4, 2026, our model estimates a fair value of 1,805 KRW versus a price of 1,245 KRW, about +45% upside (undervalued).
What is the fair value of 079950?
Our model-based fair value for INVENIA Co. Ltd is 1,805 KRW (as of Nov 4, 2026), built from audited fundamentals. The current price: 1,245 KRW.
What is the quality score of 079950?
INVENIA Co. Ltd has a Quality Score of 40/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for INVENIA Co. Ltd (079950)?
Our model-based price target is the fair value of 1,805 KRW (as of Nov 4, 2026) from 6 valuation models. Cautious scenario 1,623 KRW, optimistic scenario 1,981 KRW. It is a calculation from audited fundamentals, not an analyst target.
What is the INVENIA Co. Ltd stock forecast for 2026?
Our models put fair value at 1,805 KRW, about +45% upside versus a price of 1,245 KRW (undervalued). Cautious scenario 1,623 KRW, optimistic scenario 1,981 KRW. The calculation is refreshed regularly with new filings.
What growth is priced into INVENIA Co. Ltd (079950)?
For today's price to be fair in a discounted-cash-flow model, INVENIA Co. Ltd would have to grow free cash flow by +37.0 % per year for five years (discount rate 10.3 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew -33.5 % per year. As of Nov 4, 2026.
What discount rate (WACC) does the fair value of 079950 use?
Our models discount INVENIA Co. Ltd at 10.3 %: a base by market capitalisation (nano), damped by beta 1.06, country premium for South Korea. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For INVENIA Co. Ltd that is +37.0 % per year for five years, then slowing evenly to 2 % by year ten, using the same discount rate (10.3 %) and the same formula as our fair value.
How much growth has INVENIA Co. Ltd (079950) delivered so far?
Over the past 5 years revenue at INVENIA Co. Ltd grew -33.5 % a year. The price currently implies free-cash-flow growth of +37.0 % per year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of INVENIA Co. Ltd (079950) growing?
The median revenue growth in the sector is +11.5 % a year. That is the yardstick for the growth priced into INVENIA Co. Ltd (+37.0 % per year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of INVENIA Co. Ltd (079950)?
The free-cash-flow yield on the price is 5.92 %: that much free cash flow INVENIA Co. Ltd produces per unit of market value. When it exceeds the discount rate of our models (10.3 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of INVENIA Co. Ltd (079950)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For INVENIA Co. Ltd it is 1,805 KRW per share (as of Nov 4, 2026), against a price of 1,245 KRW. It is the blended result of 6 valuation models in 3 families (DCF Models, Asset-Based, Growth DCF).
Is INVENIA Co. Ltd stock overvalued or undervalued in 2026?
As of Nov 4, 2026, 079950 trades below its calculated fair value: price 1,245 KRW, fair value 1,805 KRW, a gap of about +45% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 079950?
No. The price is what the market pays today (1,245 KRW); the fair value is what the company's own numbers justify (1,805 KRW). For INVENIA Co. Ltd the two are 560.28 KRW per share apart. That gap is exactly why we show both numbers side by side.
How much is INVENIA Co. Ltd worth?
The market values INVENIA Co. Ltd at about 18.0B KRW (market capitalisation, as of Nov 4, 2026). Per share that is 1,245 KRW; our models calculate a fair value of 1,805 KRW per share.
What do the bullish and bearish scenarios say about 079950?
Our models span a range for INVENIA Co. Ltd: cautious scenario 1,623 KRW, base 1,805 KRW, optimistic 1,981 KRW per share (as of Nov 4, 2026, price 1,245 KRW). The range comes from different growth and margin assumptions, not from analyst opinions.
How far is 079950 from its 52-week high?
INVENIA Co. Ltd trades at 1,245 KRW, about 78% below its 52-week high of 5,740 KRW and 53% above the low of 812.00 KRW (as of Nov 6, 2026). Distance from the high says nothing about value: that is what the fair value of 1,805 KRW is for.
Which stocks are comparable to INVENIA Co. Ltd?
From the same area (Technology) we also value JUSUNG ENGINEERING Co, PSK HOLDINGS Inc, ISC Co, TSE Co, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is INVENIA Co. Ltd stock attractive at the current price?
The data as of Nov 4, 2026: price 1,245 KRW, calculated fair value 1,805 KRW (+45%), Quality Score 40/100, from 6 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 079950 calculated?
We run INVENIA Co. Ltd through 6 models from 3 families: DCF Models, Asset-Based, Growth DCF. Every model gets the same audited fundamentals; the fair value of 1,805 KRW builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.3% above its aggregate fair value. INVENIA Co. Ltd currently trades 31% below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of INVENIA Co. Ltd (079950)?
The closing price on Nov 6, 2026 was 1,245 KRW. Our model-based fair value is 1,805 KRW, about +45% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with INVENIA Co. Ltd right now?
The large discount to fair value meets weak quality (40/100). That raises the risk this is a value trap rather than a bargain. The price is below even our cautious bear case (1,623 KRW). The market is more pessimistic than our downside scenario. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution.
Key figures of INVENIA Co. Ltd
How large is the market capitalisation of INVENIA Co. Ltd (079950)?
The market capitalisation of INVENIA Co. Ltd is 18.0B KRW (≈ $13.3M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of INVENIA Co. Ltd (079950)?
The price-to-sales ratio of INVENIA Co. Ltd is 0.18 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What is the net margin of INVENIA Co. Ltd (079950)?
The net margin of INVENIA Co. Ltd is −4.9% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of INVENIA Co. Ltd (079950)?
The return on equity (ROE) of INVENIA Co. Ltd is −4,901% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of INVENIA Co. Ltd (079950)?
On an EBIT basis the return on assets of INVENIA Co. Ltd is −10.6% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of INVENIA Co. Ltd (079950)?
The operating margin of INVENIA Co. Ltd is −0.5% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at INVENIA Co. Ltd (079950)?
Revenue at INVENIA Co. Ltd is growing −75.2% versus a year earlier (3y avg −31.3%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at INVENIA Co. Ltd (079950)?
Earnings per share at INVENIA Co. Ltd are growing −60.7% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does INVENIA Co. Ltd (079950) carry?
The net debt of INVENIA Co. Ltd is 27.5B KRW (fiscal year 2025, ≈ 52.9 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch INVENIA Co. Ltd in the live analysis
One click puts INVENIA Co. Ltd on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Thin data
Nov 4, 2026